Tonix Pharmaceuticals Hol...

NASDAQ: TNXP · Real-Time Price · USD
51.66
-7.92 (-13.29%)
At close: Aug 15, 2025, 1:03 PM

Tonix Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-28.27M -16.83M -22.11M -14.21M -78.78M -14.94M -27.32M -27.98M -28.36M -33.01M -31.68M -28.98M -23.14M -26.42M -29.55M -18.53M -23.55M -20.65M
Depreciation & Amortization
483K 493K 496K 510K 1.21M 1.21M 1.49M 1.22M 921K 893K 836K 252K 102K 63K 27K 10K 7K 6K
Stock-Based Compensation
1.42M 900K 894K 1.04M 1.15M 1.69M 2.04M 2.08M 2.36M 2.79M 2.72M 2.77M 2.81M 2.62M 2.3M 2.3M 2.09M 1.21M
Other Working Capital
3.49M -3.57M 4.5M 128K -64K -3.1M 4.36M 474K 2.85M -4.17M 2.79M 3K -2.5M -4.2M 4.63M -1.29M -1.2M 116K
Other Non-Cash Items
3.94M 2.14M -328K -250.13K 61.68M -6.86M 10.74M -196K 4.54M 4M 8.78M -2.45M 2.38M 5.86M 2.3M -1.77M 3M 2.96M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -9.01M n/a -4.54M -4M -8.78M n/a -2.38M n/a -2.3M n/a n/a n/a
Change in Working Capital
7.6M -3.28M 6.42M -5.89M 4.82M 1.17M 372.37K 1.49M 1.7M -3.59M 5.83M 2.43M -946K -7.31M 4.79M 3.27M -651K -1.62M
Operating Cash Flow
-14.83M -16.58M -14.63M -18.8M -9.92M -17.57M -21.69M -23.39M -23.37M -32.91M -22.3M -23.54M -21.17M -31.05M -22.45M -12.95M -19.11M -21.06M
Capital Expenditures
-527K -6K -3K -9K 1.77K -108K -355.65K -1.81M -1.84M -3.8M -4.67M -8.82M -14.44M -20.22M -25.62M -7.75M -1.43M -505K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 257.05K 794.02K -22.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-2.01M n/a n/a 1.77K n/a n/a 7K 197.98K 324.96K n/a n/a n/a n/a n/a 25.62M n/a n/a n/a
Investing Cash Flow
-2.54M -6K -3K -9K 1.77K -108K -98.6K -821K -24.02M -3.8M -4.67M -8.82M -14.44M -20.22M -25.62M -7.75M -1.43M -505K
Debt Repayment
-423.11K -9.65M -705K -705K -705K -235K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-3.16M -3.05M n/a n/a n/a n/a n/a n/a n/a -13.96M n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.25M n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-2.65M n/a 338.94K 4K -3.11M 23K 31.51M n/a 153.45K n/a 11.48M -4.63M 27.25M 40K n/a 68K n/a 30K
Financial Cash Flow
10.99M 49.53M 85.15M 42.91M 6.91M -212K 41.29M 6.27M 1.03M -11.5M 7.23M -4.63M 72.18M 13.06M 43.77M 37.96M 22.05M 108.71M
Net Cash Flow
-6.38M 32.94M 70.54M 24.08M -2.89M -17.9M 18.03M -17.94M -46.36M -48.25M -19.75M -37M 36.54M -38.23M -4.31M 17.25M 1.5M 87.15M
Free Cash Flow
-15.36M -16.59M -14.63M -18.81M -9.92M -17.68M -22.04M -25.2M -25.21M -36.71M -26.97M -32.35M -35.61M -51.26M -48.07M -20.7M -20.54M -21.56M